PsyBio Therapeutics EPS Q/Q

What is the EPS Q/Q of PsyBio Therapeutics?

The EPS Q/Q of PsyBio Therapeutics Corp. is -75.00%

What is the definition of EPS Q/Q?



Quarterly EPS growth rate, year over year, is the increase of the company’s EPS for the most recent quarter compared to the the same quarter in the previous year.

quarterly growth yoy (year over year)

The earnings per share growth rate is an important factor for judging a company's value. EPS growth rate gives a good picture of the rate at which the company has grown its profitability in respect to the total number of shares. Comparing EPS history with stock price history helps determine the most likely future direction of the stock price.

Earnings per share is the monetary value of earnings per outstanding share of common stock for a company. The EPS is usually calculated as profit without preferred dividends divided by weighted average of common stock shares over the past twelve months.

EPS Q/Q of companies in the Health Care sector on TSXV compared to PsyBio Therapeutics

What does PsyBio Therapeutics do?

PsyBio Therapeutics Corp., a biotechnology company, focuses on the research, development, and commercialization of psychedelic-inspired regulated medicines for the treatment of mental health and other disorders in the United States. The company is headquartered in Coconut Creek, Florida.

Companies with eps q/q similar to PsyBio Therapeutics